APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Drug Detection and Analysis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug Detection and Analysis Market Analysis and Forecast 2026-2032

Report ID 174123100322 January 2026217 pages

Choose your research edition.

Industry ResearchDrug Detection and Analysis Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Detection and Analysis Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Drug Detection and Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Detection and Analysis Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Detection and Analysis Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Drug Detection and Analysis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Detection and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Detection and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Detection and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Detection and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug Detection and Analysis include Eurofins Scientific, SGS, Labcorp, Intertek, WuXi AppTec, Charles River Laboratories, ICON pIc, IQVIA and Medpace, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Detection and Analysis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Detection and Analysis, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Detection and Analysis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Detection and Analysis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Detection and Analysis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Detection and Analysis revenue, projected growth trends, production technology, application and end-user industry.

Drug Detection and Analysis Segment by Company

Eurofins Scientific

SGS

Labcorp

Intertek

WuXi AppTec

Charles River Laboratories

ICON pIc

IQVIA

Medpace

Syneos Health

Frontage Laboratories

Pace Analytical Services

Element Materials Technology

ALS Limited

STERIS

LGC Limited

Almac Group

Catalent

Cambrex

Alcami

Toxikon

Boston Analytical

Drug Detection and Analysis Segment by Type

Chemical Drug Testing

Biopharmaceutical Testing

Traditional Chinese Medicine Testing

Others

Drug Detection and Analysis Segment by Application

Pharmaceutical Companies

Biopharmaceutical Companies

Drug Regulatory Authorities

Others

Drug Detection and Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Detection and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Detection and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Detection and Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Detection and Analysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Detection and Analysis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Detection and Analysis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Detection and Analysis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Chemical Drug Testing Major Player Table 3. Biopharmaceutical Testing Major Player Table 4. Traditional Chinese Medicine Testing Major Player Table 5. Others Major Player Table 6. Global Drug Detection and Analysis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Companies Major Player Table 8. Biopharmaceutical Companies Major Player Table 9. Drug Regulatory Authorities Major Player Table 10. Others Major Player Table 11. Drug Detection and Analysis Industry Trends Table 12. Drug Detection and Analysis Industry Drivers Table 13. Drug Detection and Analysis Industry Opportunities and Challenges Table 14. Drug Detection and Analysis Industry Restraints Table 15. Global Drug Detection and Analysis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Drug Detection and Analysis Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Drug Detection and Analysis Market Share by Region (2021-2026) Table 18. Global Drug Detection and Analysis Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Drug Detection and Analysis Market Share by Region (2027-2032) Table 20. Global Drug Detection and Analysis Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Drug Detection and Analysis Revenue Market Share by Players (2021-2026) Table 22. Global Drug Detection and Analysis Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Drug Detection and Analysis Key Players Headquarters & Area Served Table 24. Global Drug Detection and Analysis Players, Product Type & Application Table 25. Global Drug Detection and Analysis Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Drug Detection and Analysis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Drug Detection and Analysis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Drug Detection and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Drug Detection and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Drug Detection and Analysis Revenue Market Share by Type (2021-2026) Table 32. Global Drug Detection and Analysis Revenue Market Share by Type (2027-2032) Table 33. Global Drug Detection and Analysis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Drug Detection and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Drug Detection and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Drug Detection and Analysis Revenue Market Share by Application (2021-2026) Table 37. Global Drug Detection and Analysis Revenue Market Share by Application (2027-2032) Table 38. Eurofins Scientific Company Information Table 39. Eurofins Scientific Business Overview Table 40. Eurofins Scientific Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Eurofins Scientific Drug Detection and Analysis Product Portfolio Table 42. Eurofins Scientific Recent Development Table 43. SGS Company Information Table 44. SGS Business Overview Table 45. SGS Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. SGS Drug Detection and Analysis Product Portfolio Table 47. SGS Recent Development Table 48. Labcorp Company Information Table 49. Labcorp Business Overview Table 50. Labcorp Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Labcorp Drug Detection and Analysis Product Portfolio Table 52. Labcorp Recent Development Table 53. Intertek Company Information Table 54. Intertek Business Overview Table 55. Intertek Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Intertek Drug Detection and Analysis Product Portfolio Table 57. Intertek Recent Development Table 58. WuXi AppTec Company Information Table 59. WuXi AppTec Business Overview Table 60. WuXi AppTec Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. WuXi AppTec Drug Detection and Analysis Product Portfolio Table 62. WuXi AppTec Recent Development Table 63. Charles River Laboratories Company Information Table 64. Charles River Laboratories Business Overview Table 65. Charles River Laboratories Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Charles River Laboratories Drug Detection and Analysis Product Portfolio Table 67. Charles River Laboratories Recent Development Table 68. ICON pIc Company Information Table 69. ICON pIc Business Overview Table 70. ICON pIc Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. ICON pIc Drug Detection and Analysis Product Portfolio Table 72. ICON pIc Recent Development Table 73. IQVIA Company Information Table 74. IQVIA Business Overview Table 75. IQVIA Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. IQVIA Drug Detection and Analysis Product Portfolio Table 77. IQVIA Recent Development Table 78. Medpace Company Information Table 79. Medpace Business Overview Table 80. Medpace Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Medpace Drug Detection and Analysis Product Portfolio Table 82. Medpace Recent Development Table 83. Syneos Health Company Information Table 84. Syneos Health Business Overview Table 85. Syneos Health Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Syneos Health Drug Detection and Analysis Product Portfolio Table 87. Syneos Health Recent Development Table 88. Frontage Laboratories Company Information Table 89. Frontage Laboratories Business Overview Table 90. Frontage Laboratories Drug Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Frontage Laboratories Drug Detection and Analysis Product Portfolio Table 92. Frontage Laboratories Recent Development Table 93. Pace Analytical Services Company Information Table 94. Pace Analytical Services Business Overview Table 95. Pace Analytical Services Drug Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Pace Analytical Services Drug Detection and Analysis Product Portfolio Table 97. Pace Analytical Services Recent Development Table 98. Element Materials Technology Company Information Table 99. Element Materials Technology Business Overview Table 100. Element Materials Technology Drug Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Element Materials Technology Drug Detection and Analysis Product Portfolio Table 102. Element Materials Technology Recent Development Table 103. ALS Limited Company Information Table 104. ALS Limited Business Overview Table 105. ALS Limited Drug Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. ALS Limited Drug Detection and Analysis Product Portfolio Table 107. ALS Limited Recent Development Table 108. STERIS Company Information Table 109. STERIS Business Overview Table 110. STERIS Drug Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. STERIS Drug Detection and Analysis Product Portfolio Table 112. STERIS Recent Development Table 113. LGC Limited Company Information Table 114. LGC Limited Business Overview Table 115. LGC Limited Drug Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. LGC Limited Drug Detection and Analysis Product Portfolio Table 117. LGC Limited Recent Development Table 118. Almac Group Company Information Table 119. Almac Group Business Overview Table 120. Almac Group Drug Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Almac Group Drug Detection and Analysis Product Portfolio Table 122. Almac Group Recent Development Table 123. Catalent Company Information Table 124. Catalent Business Overview Table 125. Catalent Drug Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Catalent Drug Detection and Analysis Product Portfolio Table 127. Catalent Recent Development Table 128. Cambrex Company Information Table 129. Cambrex Business Overview Table 130. Cambrex Drug Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Cambrex Drug Detection and Analysis Product Portfolio Table 132. Cambrex Recent Development Table 133. Alcami Company Information Table 134. Alcami Business Overview Table 135. Alcami Drug Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Alcami Drug Detection and Analysis Product Portfolio Table 137. Alcami Recent Development Table 138. Toxikon Company Information Table 139. Toxikon Business Overview Table 140. Toxikon Drug Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Toxikon Drug Detection and Analysis Product Portfolio Table 142. Toxikon Recent Development Table 143. Boston Analytical Company Information Table 144. Boston Analytical Business Overview Table 145. Boston Analytical Drug Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Boston Analytical Drug Detection and Analysis Product Portfolio Table 147. Boston Analytical Recent Development Table 148. North America Drug Detection and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 149. North America Drug Detection and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 150. North America Drug Detection and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 151. North America Drug Detection and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 152. North America Drug Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. North America Drug Detection and Analysis Revenue by Country (2021-2026) & (US$ Million) Table 154. North America Drug Detection and Analysis Revenue by Country (US$ Million) & (2027-2032) Table 155. Europe Drug Detection and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 156. Europe Drug Detection and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 157. Europe Drug Detection and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 158. Europe Drug Detection and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 159. Europe Drug Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Europe Drug Detection and Analysis Revenue by Country (2021-2026) & (US$ Million) Table 161. Europe Drug Detection and Analysis Revenue by Country (US$ Million) & (2027-2032) Table 162. China Drug Detection and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 163. China Drug Detection and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 164. China Drug Detection and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 165. China Drug Detection and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Drug Detection and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Drug Detection and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Drug Detection and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 169. Asia Drug Detection and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia Drug Detection and Analysis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Drug Detection and Analysis Revenue by Region (US$ Million) & (2021-2026) Table 172. Asia Drug Detection and Analysis Revenue by Region (US$ Million) & (2027-2032) Table 173. SAMEA Drug Detection and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Drug Detection and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Drug Detection and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 176. SAMEA Drug Detection and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 177. SAMEA Drug Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. SAMEA Drug Detection and Analysis Revenue by Country (2021-2026) & (US$ Million) Table 179. SAMEA Drug Detection and Analysis Revenue by Country (US$ Million) & (2027-2032) Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Drug Detection and Analysis Image Figure 2. Global Drug Detection and Analysis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Detection and Analysis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Chemical Drug Testing Image Figure 5. Biopharmaceutical Testing Image Figure 6. Traditional Chinese Medicine Testing Image Figure 7. Others Image Figure 8. Global Drug Detection and Analysis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Drug Detection and Analysis Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Companies Image Figure 11. Biopharmaceutical Companies Image Figure 12. Drug Regulatory Authorities Image Figure 13. Others Image Figure 14. Global Drug Detection and Analysis Market Size (US$ Million) & (2021-2032) Figure 15. Global Drug Detection and Analysis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Drug Detection and Analysis Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Drug Detection and Analysis Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Drug Detection and Analysis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Drug Detection and Analysis Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Drug Detection and Analysis Revenue Market Share by Type (2021-2032) Figure 22. Global Drug Detection and Analysis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Drug Detection and Analysis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Drug Detection and Analysis Revenue Market Share by Application (2021-2032) Figure 25. North America Drug Detection and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Drug Detection and Analysis Revenue Share by Type (2021-2032) Figure 27. North America Drug Detection and Analysis Revenue Share by Application (2021-2032) Figure 28. North America Drug Detection and Analysis Revenue Share by Country (2021-2032) Figure 29. United States Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Drug Detection and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Drug Detection and Analysis Revenue Share by Type (2021-2032) Figure 34. Europe Drug Detection and Analysis Revenue Share by Application (2021-2032) Figure 35. Europe Drug Detection and Analysis Revenue Share by Country (2021-2032) Figure 36. Germany Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Drug Detection and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Drug Detection and Analysis Revenue Share by Type (2021-2032) Figure 46. China Drug Detection and Analysis Revenue Share by Application (2021-2032) Figure 47. Asia Drug Detection and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Drug Detection and Analysis Revenue Share by Type (2021-2032) Figure 49. Asia Drug Detection and Analysis Revenue Share by Application (2021-2032) Figure 50. Asia Drug Detection and Analysis Revenue Share by Region (2021-2032) Figure 51. Japan Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Drug Detection and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Drug Detection and Analysis Revenue Share by Type (2021-2032) Figure 59. SAMEA Drug Detection and Analysis Revenue Share by Application (2021-2032) Figure 60. SAMEA Drug Detection and Analysis Revenue Share by Country (2021-2032) Figure 61. Brazil Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Drug Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical Drug Testing
  • Biopharmaceutical Testing
  • Traditional Chinese Medicine Testing
  • Others
Applications
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Drug Regulatory Authorities
  • Others
Companies covered
  • Eurofins Scientific
  • SGS
  • Labcorp
  • Intertek
  • WuXi AppTec
  • Charles River Laboratories
  • ICON pIc
  • IQVIA
  • Medpace
  • Syneos Health
  • Frontage Laboratories
  • Pace Analytical Services
  • Element Materials Technology
  • ALS Limited
  • STERIS
  • LGC Limited
  • Almac Group
  • Catalent
  • Cambrex
  • Alcami
  • Toxikon
  • Boston Analytical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Detection and Analysis Market by Type
  3. 1.2.1 Global Drug Detection and Analysis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Chemical Drug Testing
  5. 1.2.3 Biopharmaceutical Testing
  6. 1.2.4 Traditional Chinese Medicine Testing
  7. 1.2.5 Others
  8. 1.3 Drug Detection and Analysis Market by Application
  9. 1.3.1 Global Drug Detection and Analysis Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Companies
  11. 1.3.3 Biopharmaceutical Companies
  12. 1.3.4 Drug Regulatory Authorities
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Drug Detection and Analysis Market Dynamics
  1. 2.1 Drug Detection and Analysis Industry Trends
  2. 2.2 Drug Detection and Analysis Industry Drivers
  3. 2.3 Drug Detection and Analysis Industry Opportunities and Challenges
  4. 2.4 Drug Detection and Analysis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Detection and Analysis Market Perspective (2021-2032)
  2. 3.2 Global Drug Detection and Analysis Growth Trends by Region
  3. 3.2.1 Global Drug Detection and Analysis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Detection and Analysis Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Detection and Analysis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Detection and Analysis Revenue by Players
  2. 4.1.1 Global Drug Detection and Analysis Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Detection and Analysis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Detection and Analysis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Detection and Analysis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Detection and Analysis Key Players Headquarters & Area Served
  7. 4.4 Global Drug Detection and Analysis Players, Product Type & Application
  8. 4.5 Global Drug Detection and Analysis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Detection and Analysis Market CR5 and HHI
  11. 4.6.3 2025 Drug Detection and Analysis Tier 1, Tier 2, and Tier 3
5 Drug Detection and Analysis Market Size by Type
  1. 5.1 Global Drug Detection and Analysis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Detection and Analysis Revenue by Type (2021-2032)
  3. 5.3 Global Drug Detection and Analysis Revenue Market Share by Type (2021-2032)
6 Drug Detection and Analysis Market Size by Application
  1. 6.1 Global Drug Detection and Analysis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Detection and Analysis Revenue by Application (2021-2032)
  3. 6.3 Global Drug Detection and Analysis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins Scientific
  2. 7.1.1 Eurofins Scientific Company Information
  3. 7.1.2 Eurofins Scientific Business Overview
  4. 7.1.3 Eurofins Scientific Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Scientific Drug Detection and Analysis Product Portfolio
  6. 7.1.5 Eurofins Scientific Recent Developments
  7. 7.2 SGS
  8. 7.2.1 SGS Company Information
  9. 7.2.2 SGS Business Overview
  10. 7.2.3 SGS Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 SGS Drug Detection and Analysis Product Portfolio
  12. 7.2.5 SGS Recent Developments
  13. 7.3 Labcorp
  14. 7.3.1 Labcorp Company Information
  15. 7.3.2 Labcorp Business Overview
  16. 7.3.3 Labcorp Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Labcorp Drug Detection and Analysis Product Portfolio
  18. 7.3.5 Labcorp Recent Developments
  19. 7.4 Intertek
  20. 7.4.1 Intertek Company Information
  21. 7.4.2 Intertek Business Overview
  22. 7.4.3 Intertek Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Intertek Drug Detection and Analysis Product Portfolio
  24. 7.4.5 Intertek Recent Developments
  25. 7.5 WuXi AppTec
  26. 7.5.1 WuXi AppTec Company Information
  27. 7.5.2 WuXi AppTec Business Overview
  28. 7.5.3 WuXi AppTec Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 WuXi AppTec Drug Detection and Analysis Product Portfolio
  30. 7.5.5 WuXi AppTec Recent Developments
  31. 7.6 Charles River Laboratories
  32. 7.6.1 Charles River Laboratories Company Information
  33. 7.6.2 Charles River Laboratories Business Overview
  34. 7.6.3 Charles River Laboratories Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Charles River Laboratories Drug Detection and Analysis Product Portfolio
  36. 7.6.5 Charles River Laboratories Recent Developments
  37. 7.7 ICON pIc
  38. 7.7.1 ICON pIc Company Information
  39. 7.7.2 ICON pIc Business Overview
  40. 7.7.3 ICON pIc Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 ICON pIc Drug Detection and Analysis Product Portfolio
  42. 7.7.5 ICON pIc Recent Developments
  43. 7.8 IQVIA
  44. 7.8.1 IQVIA Company Information
  45. 7.8.2 IQVIA Business Overview
  46. 7.8.3 IQVIA Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 IQVIA Drug Detection and Analysis Product Portfolio
  48. 7.8.5 IQVIA Recent Developments
  49. 7.9 Medpace
  50. 7.9.1 Medpace Company Information
  51. 7.9.2 Medpace Business Overview
  52. 7.9.3 Medpace Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Medpace Drug Detection and Analysis Product Portfolio
  54. 7.9.5 Medpace Recent Developments
  55. 7.10 Syneos Health
  56. 7.10.1 Syneos Health Company Information
  57. 7.10.2 Syneos Health Business Overview
  58. 7.10.3 Syneos Health Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Syneos Health Drug Detection and Analysis Product Portfolio
  60. 7.10.5 Syneos Health Recent Developments
  61. 7.11 Frontage Laboratories
  62. 7.11.1 Frontage Laboratories Company Information
  63. 7.11.2 Frontage Laboratories Business Overview
  64. 7.11.3 Frontage Laboratories Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Frontage Laboratories Drug Detection and Analysis Product Portfolio
  66. 7.11.5 Frontage Laboratories Recent Developments
  67. 7.12 Pace Analytical Services
  68. 7.12.1 Pace Analytical Services Company Information
  69. 7.12.2 Pace Analytical Services Business Overview
  70. 7.12.3 Pace Analytical Services Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Pace Analytical Services Drug Detection and Analysis Product Portfolio
  72. 7.12.5 Pace Analytical Services Recent Developments
  73. 7.13 Element Materials Technology
  74. 7.13.1 Element Materials Technology Company Information
  75. 7.13.2 Element Materials Technology Business Overview
  76. 7.13.3 Element Materials Technology Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Element Materials Technology Drug Detection and Analysis Product Portfolio
  78. 7.13.5 Element Materials Technology Recent Developments
  79. 7.14 ALS Limited
  80. 7.14.1 ALS Limited Company Information
  81. 7.14.2 ALS Limited Business Overview
  82. 7.14.3 ALS Limited Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  83. 7.14.4 ALS Limited Drug Detection and Analysis Product Portfolio
  84. 7.14.5 ALS Limited Recent Developments
  85. 7.15 STERIS
  86. 7.15.1 STERIS Company Information
  87. 7.15.2 STERIS Business Overview
  88. 7.15.3 STERIS Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  89. 7.15.4 STERIS Drug Detection and Analysis Product Portfolio
  90. 7.15.5 STERIS Recent Developments
  91. 7.16 LGC Limited
  92. 7.16.1 LGC Limited Company Information
  93. 7.16.2 LGC Limited Business Overview
  94. 7.16.3 LGC Limited Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  95. 7.16.4 LGC Limited Drug Detection and Analysis Product Portfolio
  96. 7.16.5 LGC Limited Recent Developments
  97. 7.17 Almac Group
  98. 7.17.1 Almac Group Company Information
  99. 7.17.2 Almac Group Business Overview
  100. 7.17.3 Almac Group Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Almac Group Drug Detection and Analysis Product Portfolio
  102. 7.17.5 Almac Group Recent Developments
  103. 7.18 Catalent
  104. 7.18.1 Catalent Company Information
  105. 7.18.2 Catalent Business Overview
  106. 7.18.3 Catalent Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Catalent Drug Detection and Analysis Product Portfolio
  108. 7.18.5 Catalent Recent Developments
  109. 7.19 Cambrex
  110. 7.19.1 Cambrex Company Information
  111. 7.19.2 Cambrex Business Overview
  112. 7.19.3 Cambrex Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Cambrex Drug Detection and Analysis Product Portfolio
  114. 7.19.5 Cambrex Recent Developments
  115. 7.20 Alcami
  116. 7.20.1 Alcami Company Information
  117. 7.20.2 Alcami Business Overview
  118. 7.20.3 Alcami Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Alcami Drug Detection and Analysis Product Portfolio
  120. 7.20.5 Alcami Recent Developments
  121. 7.21 Toxikon
  122. 7.21.1 Toxikon Company Information
  123. 7.21.2 Toxikon Business Overview
  124. 7.21.3 Toxikon Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Toxikon Drug Detection and Analysis Product Portfolio
  126. 7.21.5 Toxikon Recent Developments
  127. 7.22 Boston Analytical
  128. 7.22.1 Boston Analytical Company Information
  129. 7.22.2 Boston Analytical Business Overview
  130. 7.22.3 Boston Analytical Drug Detection and Analysis Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Boston Analytical Drug Detection and Analysis Product Portfolio
  132. 7.22.5 Boston Analytical Recent Developments
8 North America
  1. 8.1 North America Drug Detection and Analysis Revenue (2021-2032)
  2. 8.2 North America Drug Detection and Analysis Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Detection and Analysis Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Detection and Analysis Revenue by Type (2027-2032)
  5. 8.3 North America Drug Detection and Analysis Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Detection and Analysis Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Detection and Analysis Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Detection and Analysis Revenue by Application (2027-2032)
  9. 8.5 North America Drug Detection and Analysis Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Detection and Analysis Revenue by Country
  11. 8.6.1 North America Drug Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Detection and Analysis Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Detection and Analysis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug Detection and Analysis Revenue (2021-2032)
  2. 9.2 Europe Drug Detection and Analysis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Detection and Analysis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Detection and Analysis Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Detection and Analysis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Detection and Analysis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Detection and Analysis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Detection and Analysis Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Detection and Analysis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Detection and Analysis Revenue by Country
  11. 9.6.1 Europe Drug Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Detection and Analysis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Detection and Analysis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug Detection and Analysis Revenue (2021-2032)
  2. 10.2 China Drug Detection and Analysis Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Detection and Analysis Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Detection and Analysis Revenue by Type (2027-2032)
  5. 10.3 China Drug Detection and Analysis Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Detection and Analysis Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Detection and Analysis Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Detection and Analysis Revenue by Application (2027-2032)
  9. 10.5 China Drug Detection and Analysis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Detection and Analysis Revenue (2021-2032)
  2. 11.2 Asia Drug Detection and Analysis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Detection and Analysis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Detection and Analysis Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Detection and Analysis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Detection and Analysis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Detection and Analysis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Detection and Analysis Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Detection and Analysis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Detection and Analysis Revenue by Country
  11. 11.6.1 Asia Drug Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Detection and Analysis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Detection and Analysis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Detection and Analysis Revenue (2021-2032)
  2. 12.2 SAMEA Drug Detection and Analysis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Detection and Analysis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Detection and Analysis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Detection and Analysis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Detection and Analysis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Detection and Analysis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Detection and Analysis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Detection and Analysis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Detection and Analysis Revenue by Country
  11. 12.6.1 SAMEA Drug Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Detection and Analysis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Detection and Analysis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst